These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7587040)

  • 1. Cefotaxime in the treatment of staphylococcal infections. Comparison of in vitro and in vivo studies.
    Aldridge KE
    Diagn Microbiol Infect Dis; 1995; 22(1-2):195-201. PubMed ID: 7587040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of cephalosporins against coagulase-negative staphylococci.
    Chin NX; Neu NM; Neu HC
    Diagn Microbiol Infect Dis; 1990; 13(1):67-9. PubMed ID: 2331853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cefotaxime in the treatment of surgical infections.
    Wittmann DH
    Diagn Microbiol Infect Dis; 1995; 22(1-2):173-82. PubMed ID: 7587036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ceftaroline against staphylococci from prosthetic joint infection.
    Park KH; Greenwood-Quaintance KE; Patel R
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):141-3. PubMed ID: 26602948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.
    Jones RN; Erwin ME; Barrett MS; Johnson DM; Briggs BM
    Diagn Microbiol Infect Dis; 1991; 14(4):301-9. PubMed ID: 1889181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response.
    Thornsberry C; Jones RN; Barry AL; Fuchs PC
    Rev Infect Dis; 1982; 4 Suppl():S316-24. PubMed ID: 6294780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus septicaemia treated with cefotaxime.
    Shah PM
    Infection; 1985; 13 Suppl 1():S34-6. PubMed ID: 4055053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with cefotaxime in infections caused by gram-positive pathogens, especially Staphylococcus aureus.
    Fujii R
    Infection; 1985; 13 Suppl 1():S9-13. PubMed ID: 4055062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Staphylococcal infection in the newborn: teicoplanin therapy].
    Fanos V; Khoory BJ; Danieli D; Padovani EM
    Pediatr Med Chir; 1993; 15(6):579-82. PubMed ID: 8197017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
    Mordenti JJ; Davis RH; Lammel CJ; Brooks GF
    Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers.
    Pfaller MA; Barry AL; Sabath LD; Kreiswirth BN; Murray PR; Fuchs PC; McLaughlin JC
    Eur J Epidemiol; 1993 Nov; 9(6):658-62. PubMed ID: 8150070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of cefepime against nosocomial isolates.
    Sofianou D; Tsoulfa S; Kontodimou L; Polydorou F; Malaka E
    J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and emerging treatment of Staphylococcus aureus infections in the hospital setting.
    Moreillon P
    Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():32-41. PubMed ID: 18318877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
    Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
    Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime use in pediatric infections.
    Dajani AS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):105-10. PubMed ID: 7587022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals.
    Murphy SP; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1994 Sep; 20(1):49-55. PubMed ID: 7867299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fosfomycin-cefotaxime combination in severe staphylococcal infections in newborn infants].
    Gouyon JB; Duez JM; Portier H; Brichon P; Kohli E; Alison M
    Presse Med; 1985 Dec; 14(42):2135-8. PubMed ID: 2935798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic susceptibility of the clinically isolated staphylococcal strains resistant to cephalosporin derivatives].
    Arai T
    Jpn J Antibiot; 1985 Feb; 38(2):199-202. PubMed ID: 3847517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro activity of cefotaxime versus bacteria involved in selected infections of hospitalized patients outside of the intensive care unit.
    Doern GV
    Diagn Microbiol Infect Dis; 1995; 22(1-2):13-7. PubMed ID: 7587027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.